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1. Introduction {#sec1}
===============

Drug abuse is one of the most serious health and social problems around the world and has attracted governments\' attentions. More and more people are infected by various drugs. Curiosity, thrill, seeking negative mentality and environmental impact are the main key factors to tempt susceptible individuals to contact with drugs. The U.S. Centers for Disease Control and Prevention in 2015 reported that from 2002 to 2013, the number of Americans over the age of 12 who snort heroin increased 63$\text{\%}$ and the deaths increased three times in America ([@bib24]). According to "China\'s drug situations report in 2015", by the end of 2015, the registered drug addicts are 2.345 million which increased by 14.6$\text{\%}$ compared to 2014 ([@bib15]). In addition, the crimes caused by taking drugs are growing rapidly, such as theft, robbery, self-injury, violence and traffic accidents and so on, which severely damage public security and public safety. It was reported by South African police statistics that the drug-related crimes increased from 621 to more than 3000 from 2002 to 2006 in Cape Town ([@bib13]). In addition, the drug abuse also aggravates the spread of infectious diseases such as hepatitis and AIDS ([@bib23]; [@bib25]). The AIDS patients increased from 13.1$\text{\%}$ in 2003 to $15.7\text{\%}$ in 2005 in the Western Cape Province of South Africa reported by antenatal survey in 2005 ([@bib26]). How to analyze the transmission mechanism of drugs better and present effective prevention measures is a problem that should be solved urgently.

Mathematical models play very important role in dealing with epidemics and biology, see ([@bib3]; [@bib6]; [@bib8]; [@bib9]; [@bib11]; [@bib16]; [@bib18]; [@bib19]) and references therein. The process of epidemics could be displayed by mathematical models vividly. As a kind of new epidemics, drug abuse and drinking have the similar characteristics with traditional epidemics, and several different mathematical models for drugs had been formulated and studied, see ([@bib17]; [@bib22]; [@bib30]). [@bib30] first presented a heroin model, in which they divided the total population into susceptible individuals, drug users not in treatment and drug users in treatment. They obtained the basic reproduction number $R_{0}$ and gave the sensitivity analysis of $R_{0}$. Then they got the conclusion that prevention was better than cure. Based on the work of ([@bib30]), [@bib17] took distributed delays into a heroin model. It was shown that the stabilities of equilibria and uniform persistence were related to the basic reproduction number $R_{0}$. In view of "light drug" and "heavy drug", [@bib22] introduced an SIRS model and discussed the global stability by applying Lyapunov function techniques. The other drug models are referred to ([@bib7]; [@bib10]; [@bib12]; [@bib21]; [@bib27]; [@bib29]).

It is well known that the social behaviour plays a vital role when infectious diseases appear and outbreak. The common ways are isolation, vaccination and publicity to the health safety and so on. Some scholars took into account of public health educational campaigns in their models. [@bib1] analyzed an HIV/AIDS model with the impact of educational programs. Mukandavire and his partners in ([@bib20]) studied the effects of public health educational campaigns on the spread of HIV/AIDS. They proved the campaigns could slow down the epidemic. For drinking, [@bib31] dealt with the global properties of a drinking model with public health education. They concluded that public health education is one of the effective measures to control the drinking problems.

Motivated by above works, we develop a six dimensional drug model with family education and public health education in the paper. According to analyze the model, we attempt to provide an effective suggestion for controlling drug transmission. The organization of this paper is as follows. In the next section, the model is built and some basic properties are derived. In Sec.[3](#sec3){ref-type="sec"}, the basic reproduction number $R_{0}$ is obtained and the stability of the drug-free equilibrium of system is discussed. In Sec.[4](#sec4){ref-type="sec"}, the existence and the stability of the drug-addiction equilibrium are investigated. In Sec.[5](#sec5){ref-type="sec"}, some numerical simulations are carried out to illustrate the theoretical results and the sensitivity analysis is performed with respect to model parameters. Some discussions and summaries are given in last section.

2. The model {#sec2}
============

2.1. The model description {#sec2.1}
--------------------------

In order to describe the spread process of drugs, we formulate a six dimensional drug model. The total population $N\left( t \right)$ is divided into six compartments: susceptible individuals who do not accept the health education(*S*), susceptible individuals who accept the health education (*C*), light drug addicts (*L*), heavy drug addicts (*H*), drug users in treatment (*T*) and quit drug-users permanently (*R*), namely, the total population at time *t* is given by $N\left( t \right) = S\left( t \right) + C\left( t \right) + L\left( t \right) + H\left( t \right) + T\left( t \right) + R\left( t \right)$. The meanings of $S,C,L,H,T$ and *R* are demonstrated concisely in [Table 1](#tbl1){ref-type="table"}. There is evidence that drug abuse phenomenon tends towards younger ([@bib4]), so we focus on the population over the age of 15 old. Generally speaking, the health education includes the family education and the public health education. The individuals before age 15 access to the drug safety education mainly from families, and after the age of 15, the corresponding education comes from society or school, which could be called public health education. We suppose that the new recruits entering the susceptible humans denoted by $d\text{Λ}$ is a part of the general population. A proportion $1 - q\left( 0 < q < 1 \right)$ of these humans do not accept family education and the complementary proportion *q* accept family health education. Meanwhile, the proportion *μ* of *S* will be educated by public health and enter into class *C*. $\beta_{1}$ and $\beta_{2}$ are the effective contact rates when susceptible humans (*S*) contact with light drug addicts (*L*) and heavy drug addicts (*H*) respectively. Generally, we assume $\beta_{2} > \beta_{1}$ because a susceptible individual is easier captured by a heavy drug addict. Once someone accepts public health education, he will reject drugs and avoid contacting with addicts consciously, so the effective contacts rates would reduce. Therefore the public health educated susceptible individuals (*C*) turn to light addicts (*L*) at rates $\beta_{1}\xi$ and $\beta_{2}\xi$ where $\xi \in \left( 0,1 \right)$. Based on the aforementioned modeling assumptions, the transfer diagram of the proposed model is shown in [Fig. 1](#fig1){ref-type="fig"}.Table 1The state variables for model.Table 1VariableDescription$S\left( t \right)$The number of susceptible drug individuals who do not accept the public health education at time *t*.$C\left( t \right)$The number of susceptible drug individuals who accept the public health education at time *t*.$L\left( t \right)$The number of light drug addicts at time *t*.$H\left( t \right)$The number of heavy drug addicts at time *t*.$T\left( t \right)$The number of drug users in treatment at time *t*.$R\left( t \right)$The number of permanent quit drug individuals at time *t*.Fig. 1The transfer diagram of drug model with health education.Fig. 1

Corresponding, the proposed model is defined by the following ordinary differential equations:$$\left\{ \begin{array}{l}
{\frac{\text{d}S}{\text{d}t} = \left( {1 - q} \right)d\text{Λ} - \beta_{1}SL - \beta_{2}SH - \left( {d + \mu} \right)S,} \\
{\frac{\text{d}C}{\text{d}t} = qd\text{Λ} + \mu S - \beta_{1}\xi CL - \beta_{2}\xi CH - \left( {d + \delta} \right)C,} \\
{\frac{\text{d}L}{\text{d}t} = \beta_{1}SL + \beta_{2}SH + \beta_{1}\xi CL + \beta_{2}\xi CH - \left( {\gamma + \pi + d + d_{1}} \right)L,} \\
{\frac{\text{d}H}{\text{d}t} = \pi L + \sigma T - \left( {\theta + d + d_{2}} \right)H,} \\
{\frac{\text{d}T}{\text{d}t} = \theta H + \gamma L - \left( {\sigma + m + d} \right)T,} \\
{\frac{\text{d}R}{\text{d}t} = \delta C + mT - dR.} \\
\end{array} \right.$$

For convenience, we list all the parameters and their meanings in [Table 2](#tbl2){ref-type="table"}.Table 2Description of parameters.Table 2ParameterDescription*d*Natural birth/death rate of humans.$\text{Λ}$The total size of new recruits.*q*popularizing rate of family education.*μ*The rate that susceptible individuals accept public health education.$\beta_{1}$The effective contact rate that susceptible individuals contact with light drug addicts.$\beta_{2}$The effective contact rate that susceptible individuals contact with heavy drug addicts.*ξ*The factor which results the effective contact rates decrease.$d_{1}$The death rate related the light drug addiction.$d_{2}$The death rate related the heavy drug addiction.*γ*The treatment rate of light drug addicts.*π*The transformation rate from light addicts to heavy addicts.*δ*The permanent quit drug rate because of public health education.*θ*The treatment rate of heavy addicts.*σ*The relapse rate after treatment.*m*The permanent quit drug rate after treatment.

Since the last equation of system [(1)](#fd1){ref-type="disp-formula"} does not have any contribution to the other equations of system [(1)](#fd1){ref-type="disp-formula"}, denote $m_{1} = \gamma + \pi + d + d_{1}$, $m_{2} = \theta + d + d_{2}$, $m_{3} = \sigma + m + d$, then from now on we only concentrate on the dynamics analysis of following reduced system:$$\left\{ \begin{array}{l}
{\frac{\text{d}S}{\text{d}t} = \left( {1 - q} \right)d\text{Λ} - \beta_{1}SL - \beta_{2}SH - \left( {d + \mu} \right)S,} \\
{\frac{\text{d}C}{\text{d}t} = qd\text{Λ} + \mu S - \beta_{1}\xi CL - \beta_{2}\xi CH - \left( {d + \delta} \right)C,} \\
{\frac{\text{d}L}{\text{d}t} = \beta_{1}SL + \beta_{2}SH + \beta_{1}\xi CL + \beta_{2}\xi CH - m_{1}L,} \\
{\frac{\text{d}H}{\text{d}t} = \pi L + \sigma T - m_{2}H,} \\
{\frac{\text{d}T}{\text{d}t} = \theta H + \gamma L - m_{3}T,} \\
\end{array} \right.$$with the initial condition$$\begin{array}{l}
{S\left( 0 \right) = S_{0} > 0,\quad C\left( 0 \right) = C_{0} > 0,\quad L\left( 0 \right) = L_{0} > 0,} \\
{H\left( 0 \right) = H_{0} > 0,\quad T\left( 0 \right) = T_{0} > 0.} \\
\end{array}$$

From the point of view of biology, we only care about the dynamics of system [(2)](#fd2){ref-type="disp-formula"} in the feasible region as follows:$$\text{Ω} = \left\{ \left( S,C,L,H,T \right) \middle| S \geq 0,C \geq 0,L \geq 0,H \geq 0,T \geq 0,S + C + L + H + T \leq \text{Λ} \right\}$$

In the next subsection, it can be showed that the set $\text{Ω}$ is positively invariant.

2.2. The basic properties {#sec2.2}
-------------------------

For system [(2)](#fd2){ref-type="disp-formula"}, it is necessary to prove all of solutions with initial conditions [(3)](#fd3){ref-type="disp-formula"} remain positive for all $t \geq 0$. We first state the following conclusions:Lemma 2.1*All the solutions of system* [(2)](#fd2){ref-type="disp-formula"} *with initial conditions* [(3)](#fd3){ref-type="disp-formula"} *are nonnegative for all* $t \geq 0$*. For system* [(2)](#fd2){ref-type="disp-formula"}*, the set* $\text{Ω}$ *is positively invariant.*ProofSuppose $\left( {S,C,L,H,T} \right)$ is any solution of model [(2)](#fd2){ref-type="disp-formula"}, we have$$\begin{array}{ll}
\left. \frac{\text{d}S}{\text{d}t} \middle| {}_{S = 0} = \left( {1 - q} \right)d\text{Λ} > 0, \right. & \left. \frac{\text{d}C}{\text{d}t} \middle| {}_{C = 0} = qd\text{Λ} + \mu S \geq 0, \right. \\
\left. \frac{\text{d}L}{\text{d}t} \middle| {}_{L = 0} = \beta_{2}SH + \beta_{2}\xi CH \geq 0, \right. & \left. \frac{\text{d}H}{\text{d}t} \middle| {}_{H = 0} = \pi L + \sigma T \geq 0, \right. \\
\left. \frac{\text{d}T}{\text{d}t} \middle| {}_{T = 0} = \theta H + \gamma L \geq 0. \right. & \\
\end{array}$$

With the continuity of the solution of system [(2)](#fd2){ref-type="disp-formula"}, $S\left( t \right) > 0,C\left( t \right) > 0,L\left( t \right) > 0,H\left( t \right) > 0,T\left( t \right) > 0$ for all $t \geq 0$.

Adding all the equations of system [(2)](#fd2){ref-type="disp-formula"}, it is obtained$$\begin{matrix}
{\frac{\text{d}\left( {S + C + L + H + T} \right)}{\text{d}t} = d\text{Λ} - d\left( {S + C + L + H + T} \right) - d_{1}L - d_{2}H} \\
{\leq d\text{Λ} - d\left( {S + C + L + H + T} \right).} \\
\end{matrix}$$

Thus from Birkhoff\'s and Rota\'s theorems ([@bib2]), it follows $0 \leq S + C + L + H + T \leq \text{Λ}$ as $\left. t\rightarrow\infty \right.$, so the region $\text{Ω}$ is a positively invariant set.

3. The drug-free equilibrium $E_{0}$ {#sec3}
====================================

The basic reproduction number $R_{0}$ is an important index in epidemiology. It is a threshold value which could represent how many secondary infections result from the introduction of one infected individual into a population of susceptible ([@bib5]). In the section, we calculate the basic reproduction number $R_{0}$ and give the kinetic properties of the drug-free equilibrium $E_{0}$.

3.1. The basic reproduction number {#sec3.1}
----------------------------------

There always exists a drug-free equilibrium $E_{0} = \left( {S_{0},C_{0},0,0,0} \right)$ of system [(2)](#fd2){ref-type="disp-formula"}, where $S_{0} = \frac{\left( {1 - q} \right)d\text{Λ}}{d + \mu},C_{0} = \frac{\left( {\mu + qd} \right)d\text{Λ}}{\left( {d + \delta} \right)\left( {d + \mu} \right)}$. Next, the basic reproduction number of system [(2)](#fd2){ref-type="disp-formula"} will be obtained applying the next generation matrix ([@bib28]) and the local stability of drug-free equilibrium $E_{0}$ will be established.

Rewrite $X = \left( {L,H,T,S,C} \right)$, then it follows from system [(2)](#fd2){ref-type="disp-formula"} that $\frac{\text{d}X}{\text{d}t} = \mathbb{F} - \mathbb{V}$, where$$\begin{array}{l}
{\mathbb{F} = \left( \begin{array}{l}
{\left( {S + \xi C} \right)\left( {\beta_{1}L + \beta_{2}H} \right)} \\
0 \\
0 \\
0 \\
0 \\
\end{array} \right),} \\
{\mathbb{V} = \left( \begin{array}{l}
{m_{1}L} \\
{m_{2}H - \pi L - \sigma T} \\
{m_{3}T - \theta H - \gamma L} \\
{S\left( {\beta_{1}L + \beta_{2}H} \right) + \left( {d + \mu} \right)S - \left( {1 - q} \right)d\text{Λ}} \\
{\xi C\left( {\beta_{1}L + \beta_{2}H} \right) + \left( {d + \delta} \right)C - qd\text{Λ} - \mu S} \\
\end{array} \right).} \\
\end{array}$$

Thus the corresponding linearized matrixes evaluated at drug-free equilibrium $E_{0}$ are$$F\left( E_{0} \right) = \begin{pmatrix}
{\beta_{1}\left( {S_{0} + \xi C_{0}} \right)} & {\beta_{2}\left( {S_{0} + \xi C_{0}} \right)} & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & 0 \\
\end{pmatrix},$$and$$V\left( E_{0} \right) = \begin{pmatrix}
m_{1} & 0 & 0 & 0 & 0 \\
{- \pi} & m_{2} & {- \sigma} & 0 & 0 \\
{- \gamma} & {- \theta} & m_{3} & 0 & 0 \\
{\beta_{1}S_{0}} & {\beta_{2}S_{0}} & 0 & {d + \mu} & 0 \\
{\beta_{1}\xi C_{0}} & {\beta_{2}\xi C_{0}} & 0 & {- \mu} & {d + \delta} \\
\end{pmatrix}.$$

Obviously, $F\left( E_{0} \right)$ is non-negative. By directly calculate, the basic reproduction number $R_{0} = \rho\left( {FV^{- 1}} \right) = \left( {S_{0} + \xi C_{0}} \right)\frac{\beta_{1}\widetilde{A} + \beta_{2}}{m_{1}\widetilde{A}}$, where $\widetilde{A} = \frac{m_{2}m_{3} - \theta\sigma}{m_{3}\pi + \sigma\gamma}$. Here, we can interpret the dimensionless quantity $R_{0}$ is the drug generation number which could measure the average number of new drug users generated by a drug addict in a population of susceptible individuals.

By Theorem 2 in ([@bib28]), the following conclusion is obvious:Theorem 3.1*For system* [(2)](#fd2){ref-type="disp-formula"}*, the drug-free equilibrium* $E_{0}$ *is locally asymptotically stable if* $R_{0} < 1$ *and unstable if* $R_{0} > 1$.

3.2. The global stability of the drug-free equilibrium $E_{0}$ {#sec3.2}
--------------------------------------------------------------

In this subsection, the global stability of the drug-free equilibrium $E_{0}$ will be established by applying the Lyapunov functional technique.Theorem 3.2*For system* [(2)](#fd2){ref-type="disp-formula"}*, the drug-free equilibrium* $E_{0}$ *is globally asymptotically stable when* $R_{0} \leq 1$.Proof*Define Lyapunov function as follows*:$$\begin{array}{l}
{V = S - S_{0} - S_{0}\ \ln\frac{S}{S_{0}} + C - C_{0} - C_{0}\ \ln\frac{C}{C_{0}} + L} \\
{\quad + \frac{m_{3}\left( {m_{1} - \beta_{1}\left( {S_{0} + \xi C_{0}} \right)} \right)}{\pi m_{3} + \sigma\gamma}H + \frac{\sigma\left( {m_{1} - \beta_{1}\left( {S_{0} + \xi C_{0}} \right)} \right)}{\pi m_{3} + \sigma\gamma}T,} \\
\end{array}$$then the derivative of *V* is given by$$\begin{array}{l}
{V^{\prime} = \left( {1 - \frac{S_{0}}{S}} \right)S^{\prime} + \left( {1 - \frac{C_{0}}{C}} \right)C^{\prime} + L^{\prime} + \widetilde{B}H^{\prime} + \xi T^{\prime}} \\
{= \left( {S - S_{0}} \right)\left( {\left( {1 - q} \right)d\text{Λ}\left( {\frac{1}{S} - \frac{1}{S_{0}}} \right) - \beta_{1}L - \beta_{2}H} \right)} \\
{+ \left( {C - C_{0}} \right)\left( {qd\text{Λ}\left( {\frac{1}{C} - \frac{1}{C_{0}}} \right) + \mu\left( {\frac{S}{C} - \frac{S_{0}}{C_{0}}} \right) - \beta_{1}\xi L - \beta_{2}\xi H} \right)} \\
{+ \left( {\beta_{1}L + \beta_{2}H} \right)\left( {\left( {S - S_{0}} \right) + \xi\left( {C - C_{0}} \right) + S_{0} + \xi C_{0}} \right)} \\
{- m_{1}L + \frac{m_{3}\left( {m_{1} - \beta_{1}\left( {S_{0} + \xi C_{0}} \right)} \right)}{\pi m_{3} + \sigma\gamma}\left( {\pi L + \sigma T - m_{2}H} \right)} \\
{+ \frac{\sigma\left( {m_{1} - \beta_{1}\left( {S_{0} + \xi C_{0}} \right)} \right)}{\pi m_{3} + \sigma\gamma}\left( {\theta H + \gamma L - m_{3}T} \right)} \\
{= \left( {1 - q} \right)d\text{Λ}\left( {2 - \frac{S}{S_{0}} - \frac{S_{0}}{S}} \right) + qd\text{Λ}\left( {2 - \frac{C}{C_{0}} - \frac{C_{0}}{C}} \right)} \\
{+ \mu S_{0}\left( {1 + \frac{S}{S_{0}} - \frac{C}{C_{0}} - \frac{SC_{0}}{CS_{0}}} \right) + f\left( H \right)} \\
{= qd\text{Λ}\left( {2 - \frac{C}{C_{0}} - \frac{C_{0}}{C}} \right) + dS_{0}\left( {2 - \frac{S}{S_{0}} - \frac{S_{0}}{S}} \right)} \\
{+ \mu S_{0}\left( {3 - \frac{S_{0}}{S} - \frac{C}{C_{0}} - \frac{SC_{0}}{S_{0}C}} \right) + f\left( H \right),} \\
\end{array}$$where$$\begin{matrix}
{f\left( H \right) = \left( {\beta_{2}\left( {S_{0} + \xi C_{0}} \right) + \widetilde{A}\left( {\beta_{1}\left( {S_{0} + \xi C_{0}} \right) - m_{1}} \right)} \right)H} \\
{= \left( {\left( {\beta_{2} + \beta_{1}\widetilde{A}} \right)\left( {S_{0} + \xi C_{0}} \right) - \widetilde{A}m_{1}} \right)H} \\
{= m_{1}\widetilde{A}\left( {R_{0} - 1} \right)H,} \\
\end{matrix}$$and$$\widetilde{B} = \frac{m_{3}\left( {m_{1} - \beta_{1}\left( {S_{0} + \xi C_{0}} \right)} \right)}{\pi m_{3} + \sigma\gamma},\xi = \frac{\sigma\left( {m_{1} - \beta_{1}\left( {S_{0} + \xi C_{0}} \right)} \right)}{\pi m_{3} + \sigma\gamma}$$

It is easy to see $f\left( H \right) \leq 0$ when $R_{0} \leq 1$. Furthermore, $f\left( H \right) = 0$ if and only if $R_{0} = 1$. Meanwhile, by arithmetic geometric average inequality, we have$$\begin{array}{l}
{2 - \frac{S}{S_{0}} - \frac{S_{0}}{S} \leq 0,\quad\quad 2 - \frac{C}{C_{0}} - \frac{C_{0}}{C} \leq 0,} \\
{3 - \frac{S_{0}}{S} - \frac{C}{C_{0}} - \frac{SC_{0}}{S_{0}C} \leq 0.} \\
\end{array}$$

Therefore, $V^{\prime} \leq 0$ for $S,C > 0$, and $V^{\prime} = 0$ holds if and only if $C = C_{0},S = S_{0}$ and $R_{0} = 1$. The largest invariant set in *G* is the singleton $E_{0}$. By [@bib14], the drug-free equilibrium $E_{0}$ is globally asymptotically stable.

4. The drug addiction equilibrium $E^{\text{*}}$ of system [(2)](#fd2){ref-type="disp-formula"} {#sec4}
===============================================================================================

Now, we shall investigate the existence of the drug addiction equilibrium of system [(2)](#fd2){ref-type="disp-formula"}. The global stability of $E^{\text{*}}$ is considered in detail using Lyapunov function.

4.1. The existence of the drug addiction equilibrium $E^{\text{*}}$ {#sec4.1}
-------------------------------------------------------------------

Let the right of system [(2)](#fd2){ref-type="disp-formula"} is equal to zero, that is$$\left\{ \begin{array}{l}
{\left( {1 - q} \right)d\text{Λ} - \beta_{1}SL - \beta_{2}SH - \left( {d + \mu} \right)S = 0,} \\
{qd\text{Λ} + \mu S - \beta_{1}\xi CL - \beta_{2}\xi CH - \left( {d + \delta} \right)C = 0,} \\
{\beta_{1}SL + \beta_{2}SH + \beta_{1}\xi CL + \beta_{2}\xi CH - m_{1}L = 0,} \\
{\pi L + \sigma T - m_{2}H = 0,} \\
{\theta H + \gamma L - m_{3}T = 0,} \\
\end{array} \right.$$then the drug addiction equilibrium $E^{\text{*}} = \left( {S^{\text{*}},C^{\text{*}},L^{\text{*}},H^{\text{*}},T^{\text{*}}} \right)$ is determined by system [(5)](#fd5){ref-type="disp-formula"}. Solving all equations of system [(5)](#fd5){ref-type="disp-formula"}, we get$$L^{\text{*}} = \widetilde{A}H^{\text{*}},\quad T^{\text{*}} = \frac{\pi\theta + m_{2}\gamma}{m_{3}\pi + \sigma\gamma}H^{\text{*}},\quad S^{\text{*}} = \frac{\left( {1 - q} \right)d\text{Λ}}{\left( {\beta_{1}\widetilde{A} + \beta_{2}} \right)H^{\text{*}} + d + \mu}.$$

Summing the first three equations of system [(5)](#fd5){ref-type="disp-formula"}, we get$$C^{\text{*}} = \frac{d\left( {\text{Λ} - S^{\text{*}}} \right) - m_{1}\widetilde{A}H^{\text{*}}}{d + \delta}.$$$H^{\text{*}}$ is the root of following equation:$$aH^{2} + bH + c = 0,$$where$$\begin{array}{l}
{a = \left( {\beta_{1}\widetilde{A} + \beta_{2}} \right)^{2}\xi m_{1}\widetilde{A},} \\
{b = \left( {\beta_{1}\widetilde{A} + \beta_{2}} \right)\left( {\left( {d + \mu} \right)\xi m_{1}\widetilde{A} - \left( {\beta_{1}\widetilde{A} + \beta_{2}} \right)\xi d\text{Λ} + m_{1}\widetilde{A}\left( {d + \delta} \right)} \right),} \\
{c = \left( {d + \mu} \right)\left( {d + \delta} \right)m_{1}\widetilde{A} - d\text{Λ}\left( {\beta_{1}\widetilde{A} + \beta_{2}} \right)\left( {\left( {1 - q} \right)\left( {d + \delta} \right) + \xi\left( {\mu + qd} \right)} \right)} \\
{= \left( {d + \mu} \right)\left( {d + \delta} \right)m_{1}\widetilde{A}\left( {1 - R_{0}} \right).} \\
\end{array}$$

It is easy to verify that if $R_{0} \leq 1$, then $c \geq 0,b > 0$, there is no positive root of equation [(8)](#fd8){ref-type="disp-formula"}; if $R_{0} > 1$, then $c < 0$, equation [(8)](#fd8){ref-type="disp-formula"} exists a unique positive root $H^{\text{*}}$. The conclusion is described by the following theorem:Theorem 4.1*When* $R_{0} > 1$, *the system* [(2)](#fd2){ref-type="disp-formula"} *exist a unique positive equilibrium* $E^{\text{*}} = \left( {S^{\text{*}},C^{\text{*}},L^{\text{*}},H^{\text{*}},T^{\text{*}}} \right)$, *where* $S^{\text{*}},C^{\text{*}},L^{\text{*}},T^{\text{*}}$ *are described as* [(6)](#fd6){ref-type="disp-formula"} *and* [(7)](#fd7){ref-type="disp-formula"}, $H^{\text{*}}$ *is the unique positive root of* equation [(8)](#fd8){ref-type="disp-formula"}.

4.2. The global stability of the drug addiction equilibrium $E^{\text{*}}$ {#sec4.2}
--------------------------------------------------------------------------

In the subsection, we show the drug addiction equilibrium $E^{\text{*}}$ is globally asymptotically stable under certain conditions by using Lyapunov function.Theorem 4.2*When* $R_{0} > 1$ *and* $\frac{\left( {m_{3}\pi + \sigma\gamma} \right)d\text{Λ}}{m_{3}\pi\left( {d + \mu} \right)} < \frac{m_{1}\widetilde{A}}{\beta_{1}\widetilde{A} + \beta_{2}} < \frac{qd}{\beta_{2}}$*, the equilibrium* $E^{\text{*}}$ *of system* [(2)](#fd2){ref-type="disp-formula"} *is globally asymptotically stable.*ProofDenote $K = \frac{\beta_{2}\left( {S^{\text{*}} + \xi C^{\text{*}}} \right)}{m_{2}m_{3} - \theta\sigma}$ and $x = \frac{S^{\text{*}}}{S},\ y = \frac{C^{\text{*}}}{C},\ z = \frac{L^{\text{*}}}{L},\ v = \frac{H^{\text{*}}}{H},\ w = \frac{T^{\text{*}}}{T}$. Construct the Lyapunov function to the drug addiction equilibrium $E^{\text{*}}$ of system [(2)](#fd2){ref-type="disp-formula"} as follows:$$\begin{matrix}
{V = \left( {S - S^{\text{*}} - S^{\text{*}}\ \ln\frac{S}{S^{\text{*}}}} \right) + \left( {C - C^{\text{*}} - C^{\text{*}}\ \ln\frac{C}{C^{\text{*}}}} \right) + \left( {L - L^{\text{*}} - L^{\text{*}}\ \ln\frac{L}{L^{\text{*}}}} \right)} \\
{\quad + K\left( {m_{3}\left( {H - H^{\text{*}} - H^{\text{*}}\ \ln\frac{H}{H^{\text{*}}}} \right) + \sigma\left( {T - T^{\text{*}} - T^{\text{*}}\ \ln\frac{T}{T^{\text{*}}}} \right)} \right).} \\
\end{matrix}$$

Calculating the derivative of *V* along solution of system [(2)](#fd2){ref-type="disp-formula"}, we obtain$$\begin{array}{l}
{\overset{˙}{V} = \left( {1 - \frac{S^{\text{*}}}{S}} \right)\overset{˙}{S} + \left( {1 - \frac{C^{\text{*}}}{C}} \right)\overset{˙}{C} + \left( {1 - \frac{L^{\text{*}}}{L}} \right)\overset{˙}{L} + Km_{3}\left( {1 - \frac{H^{\text{*}}}{H}} \right)\overset{˙}{H} + K\sigma\left( {1 - \frac{T^{\text{*}}}{T}} \right)\overset{˙}{T}} \\
{= \left( {1 - x} \right)\left( {\beta_{1}S^{\text{*}}L^{\text{*}}\left( {1 - \frac{1}{xz}} \right) + \beta_{2}S^{\text{*}}H^{\text{*}}\left( {1 - \frac{1}{xv}} \right) + \left( {d + \mu} \right)S^{\text{*}}\left( {1 - \frac{1}{x}} \right)} \right)} \\
{+ \left( 1 - y \right)(\mu S^{\text{*}}\left( \frac{1}{x} - 1 \right) + \beta_{1}\xi C^{\text{*}}L^{\text{*}}\left( 1 - \frac{1}{yz} \right) + \beta_{2}\xi C^{\text{*}}H^{\text{*}}\left( 1 - \frac{1}{yv} \right)} \\
{+ \left( d + \delta \right)C^{\ast}\left( {1 - \frac{1}{y}} \right)) + \left( 1 - z \right)\left( \beta_{1}S^{\ast}L^{\ast}\left( {\frac{1}{xz} - 1} \right) \right. + \beta_{2}S^{\ast}H^{\ast}\left( {\frac{1}{xv} - 1} \right)} \\
\left. + \beta_{1}\xi C^{\text{*}}L^{\text{*}}\left( \frac{1}{yz} - 1 \right) + \beta_{2}\xi C^{\text{*}}H^{\text{*}}\left( \frac{1}{yv} - 1 \right) + m_{1}L^{\text{*}}\left( 1 - \frac{1}{z} \right) \right) \\
{+ m_{3}K\left( {1 - v} \right)\left( {\pi L^{\text{*}}\left( {\frac{1}{z} - 1} \right) + \sigma T^{\text{*}}\left( {\frac{1}{w} - 1} \right) + m_{2}H^{\text{*}}\left( {1 - \frac{1}{v}} \right)} \right)} \\
{+ \sigma K\left( {1 - w} \right)\left( {\theta H^{\text{*}}\left( {\frac{1}{v} - 1} \right) + \gamma L^{\text{*}}\left( {\frac{1}{z} - 1} \right) + m_{3}T^{\text{*}}\left( {1 - \frac{1}{w}} \right)} \right)} \\
{= \mu S^{\text{*}} + 2dS^{\text{*}} + 2\left( {d + \delta} \right)C^{\text{*}} + 2m_{1}L^{\text{*}} + m_{2}m_{3}KH^{\text{*}} + m_{3}\sigma KT^{\text{*}}} \\
{- \left( {1 - q} \right)d\text{Λ}x - qd\text{Λ}y - \left( {\left( {d + \delta} \right)C^{\text{*}} + \beta_{1}\xi C^{\text{*}}L^{\text{*}}} \right)\frac{1}{y} - \left( {\beta_{1}S^{\text{*}}L^{\text{*}} + dS^{\text{*}}} \right)\frac{1}{x}} \\
{- \mu S^{\text{*}}\frac{y}{x} - K\left( {m_{3}\pi L^{\text{*}}\frac{v}{z} + m_{3}\sigma T^{\text{*}}\frac{v}{w} + \sigma\theta H^{\text{*}}\frac{w}{v} + \sigma\gamma L^{\text{*}}\frac{w}{z}} \right)} \\
{- \beta_{2}S^{\text{*}}H^{\text{*}}\frac{z}{xv} - \beta_{2}\xi C^{\text{*}}H^{\text{*}}\frac{z}{yv}} \\
{= \mu S^{\text{*}} + 2dS^{\text{*}} + 2\left( {d + \delta} \right)C^{\text{*}} + 2m_{1}L^{\text{*}} + m_{3}K\left( {\pi L^{\text{*}} + \sigma T^{\text{*}}} \right) + \sigma K\left( {\theta H^{\text{*}} + \gamma L^{\text{*}}} \right)} \\
{- \left( {\beta_{1}S^{\text{*}}L^{\text{*}} + dS^{\text{*}}} \right)\left( {x + \frac{1}{x}} \right) - \mu S^{\text{*}}\left( {x + \frac{y}{x} + \frac{1}{y}} \right) - \sigma K\theta H^{\text{*}}\left( {\frac{v}{w} + \frac{w}{v}} \right)} \\
{- \beta_{2}S^{\text{*}}H^{\text{*}}\left( {x + \frac{z}{xv} + \frac{v}{z}} \right) - \sigma K\gamma L^{\text{*}}\left( {\frac{v}{w} + \frac{w}{z} + \frac{z}{yv} + y} \right)} \\
{- \left( {m_{3}K\pi L^{\text{*}} - \beta_{2}S^{\text{*}}H^{\text{*}}} \right)\left( {y + \frac{z}{yv} + \frac{v}{z}} \right) - \left( {qd\text{Λ} - \beta_{2}\xi C^{\text{*}}H^{\text{*}}} \right)\left( {y + \frac{1}{y}} \right).} \\
\end{array}$$

Since $\frac{\left( {m_{3}\pi + \sigma\gamma} \right)d\text{Λ}}{m_{3}\pi\left( {d + \mu} \right)} < \frac{m_{1}\widetilde{A}}{\beta_{1}\widetilde{A} + \beta_{2}}$, then$$\begin{array}{l}
{\left( {m_{3}K\pi L^{\text{*}} - \beta_{2}S^{\text{*}}H^{\text{*}}} \right) = \beta_{2}H^{\text{*}}\frac{m_{3}\pi\xi C^{\text{*}} - \sigma\gamma S^{\text{*}}}{m_{3}\pi + \sigma\gamma}} \\
{= \frac{\beta_{2}H^{\text{*}}}{m_{3}\pi + \sigma\gamma}\left( {\frac{m_{3}\pi m_{1}\widetilde{A}}{\beta_{1}\widetilde{A} + \beta_{2}} - \left( {m_{3}\pi + \sigma\gamma} \right)S^{\text{*}}} \right)} \\
{> \frac{\beta_{2}H^{\text{*}}}{m_{3}\pi + \sigma\gamma}\left( {\frac{m_{3}\pi m_{1}\widetilde{A}}{\beta_{1}\widetilde{A} + \beta_{2}} - \left( {m_{3}\pi + \sigma\gamma} \right)\frac{\left( {1 - q} \right)d\text{Λ}}{d + \mu}} \right)} \\
{> \frac{\beta_{2}H^{\text{*}}}{m_{3}\pi + \sigma\gamma}\left( {\frac{m_{3}\pi m_{1}\widetilde{A}}{\beta_{1}\widetilde{A} + \beta_{2}} - \left( {m_{3}\pi + \sigma\gamma} \right)\frac{d\text{Λ}}{d + \mu}} \right)} \\
{> 0,} \\
\end{array}$$and since $\frac{m_{1}\widetilde{A}}{\beta_{1}\widetilde{A} + \beta_{2}} < \frac{qd}{\beta_{2}}$, then$$\begin{array}{l}
{qd\text{Λ} - \beta_{2}\xi C^{\text{*}}H^{\text{*}} > qd\text{Λ} - \beta_{2}\frac{m_{1}\widetilde{A}}{\beta_{1}\widetilde{A} + \beta_{2}}H^{\text{*}}} \\
{> \left( {qd - \beta_{2}\frac{m_{1}\widetilde{A}}{\beta_{1}\widetilde{A} + \beta_{2}}} \right)\text{Λ}} \\
{> 0.} \\
\end{array}$$

Using arithmetic geometric average inequality, we obtain$$\begin{array}{l}
{\overset{˙}{V} \leq \mu S^{\text{*}} + 2dS^{\text{*}} + 2\left( {d + \delta} \right)C^{\text{*}} + 2m_{1}L^{\text{*}} + m_{3}K\left( {\pi L^{\text{*}} + \sigma T^{\text{*}}} \right) + \sigma K\left( {\theta H^{\text{*}} + \gamma L^{\text{*}}} \right)} \\
{\mspace{34mu} - 2\left( {\beta_{1}L^{\text{*}} + d} \right)S^{\text{*}} - 3\mu S^{\text{*}} - 3\beta_{2}S^{\text{*}}H^{\text{*}} - 3\left( {m_{3}K\pi L^{\text{*}} - \beta_{2}S^{\text{*}}H^{\text{*}}} \right)} \\
{\mspace{34mu} - 2\sigma K\theta H^{\text{*}} - 4\sigma K\gamma L^{\text{*}} - 2\left( {\left( {d + \delta} \right)C^{\text{*}} + \beta_{1}\xi C^{\text{*}}L^{\text{*}} - \mu S^{\text{*}}} \right)} \\
{\quad = 2\left( {m_{1}L^{\text{*}} - \beta_{1}S^{\text{*}}H^{\text{*}} - \beta_{2}\xi C^{\text{*}}H^{\text{*}} - \beta_{1}\xi C^{\text{*}}L^{\text{*}} - \beta_{1}L^{\text{*}}S^{\text{*}}} \right)} \\
{\quad = 0.} \\
\end{array}$$

The $V^{\prime} = 0$ holds if and only if $x = y = 1,v = z = w$. Therefore the singleton drug-addiction equilibrium $E^{\text{*}}$ is the maximum invariant set of system [(2)](#fd2){ref-type="disp-formula"} on the set $\text{Ω'} = \left\{ \left( S,C,L,H,T \right) \middle| S = S^{\text{*}},C = C^{\text{*}},\frac{L^{\text{*}}}{L} = \frac{H^{\text{*}}}{H} = \frac{T^{\text{*}}}{T} \right\} \subset \text{Ω}$. By [@bib14], the drug addiction equilibrium $E^{\text{*}}$ is globally asymptotically stable.

5. Sensitivity and numerical simulation {#sec5}
=======================================

In the section, some numerical simulations are present in order to illustrate the theoretical results obtained above. We show the stabilities of equilibria of system [(2)](#fd2){ref-type="disp-formula"}. Some parameters of the model come from reference ([@bib12]; [@bib25]), $d = 0.02,\beta_{1} = 0.7,\beta_{2} = 0.8,d_{1} = 0.2,d_{2} = 0.3,\pi = 0.03,\gamma = 0.3,\theta = 0.421,\xi = 0.9,m = 0.25,\sigma = 0.7$, and the rest of the parametric values are estimated for numerical requirement.Example 5.1Fix $\text{Λ} = 1.2,\delta = 0.04,q = 0.8,\mu = 0.1$, then $R_{0} = 0.812019 < 1$, the drug-free equilibrium $E_{0}$ is globally asymptotically stable (see [Fig. 2](#fig2){ref-type="fig"}(a)).Fig. 2The stabilities of equilibria of system [(2)](#fd2){ref-type="disp-formula"}.Fig. 2Example 5.2Fix $\text{Λ} = 1.2,\delta = 0.01,q = 0.4,\mu = 0.1$, then $R_{0} = 1.60729 > 1$, the drug addiction equilibrium $E^{\text{*}}$ is globally asymptotically stable (see [Fig. 2](#fig2){ref-type="fig"}(b)).

For infectious diseases, if the basic reproduction number can decrease below unity, the diseases would be controlled. In order to achieve the goal, it is essential to consider the sensitivity of parameters, especially *q* and *μ*. First, we calculate the following partial derivatives.$$\begin{array}{l}
{\frac{\partial R_{0}}{\partial\sigma} = \frac{\beta_{2}\left( {S_{0} + \xi C_{0}} \right)}{m_{1}{\widetilde{A}}^{2}}\frac{m_{3}\left( {m_{2}\gamma + \theta\pi} \right)\sigma}{\left( {m_{3}\pi + \sigma\gamma} \right)^{2}} > 0,} \\
{\frac{\partial R_{0}}{\partial m} = - \frac{\beta_{2}\left( {S_{0} + \xi C_{0}} \right)}{m_{1}{\widetilde{A}}^{2}}\frac{\left( {m_{2}\gamma + \theta\pi} \right)\sigma}{\left( {m_{3}\pi + \sigma\gamma} \right)^{2}} < 0.} \\
\end{array}$$

It is showed that decreasing the relapse rate *σ* could reduce the basic reproduction number, and increasing the quit drug rate permanently also achieve the same result. Furthermore, we pay attention to the effect of family education and public health education on the drug model in the paper, so the partial derivatives of $R_{0}$ with respect to *q* and *μ* are calculated as follows:$$\begin{array}{l}
{\frac{\partial R_{0}}{\partial q} = \frac{\left( {\beta_{1}\widetilde{A} + \beta_{2}} \right)d\text{Λ}}{m_{1}\widetilde{A}\left( {d + \mu} \right)}\frac{d\xi - d - \delta}{d + \delta} < 0,} \\
{\frac{\partial R_{0}}{\partial\mu} = \frac{\left( {\beta_{1}\widetilde{A} + \beta_{2}} \right)d\text{Λ}\left( {1 - q} \right)}{m_{1}\widetilde{A}\left( {d + \mu} \right)^{2}}\left( {\frac{d}{d + \delta} - 1} \right) < 0.} \\
\end{array}$$

From the results we can see that the basic reproduction number $R_{0}$ can be less than unit if reinforce the public health education. At last, we simulate the relationship among the basic reproduction number $R_{0}$, the popularizing rate of family education *q* and the public health education rate *μ*.Example 5.3Fix $\text{Λ} = 1.2,\delta = 0.02$, then the relationship of $R_{0}$, q and μ is showed in [Fig. 3](#fig3){ref-type="fig"}. The image shows q and μ have an inversely proportional relationship with $R_{0}$, which is consistent with above theoretical calculation.Fig. 3The relationship among the basic reproduction number $R_{0}$, *q* and *μ*.Fig. 3

6. Discussion and summary {#sec6}
=========================

In the paper, we formulated a drug model in order to study the effect of the family and public health education on drugs spread. In the model, the drug addicts were divided into light drug addicts and heavy drug addicts and the permanent quit drug was considered. Due to the influence of public health education, the effective contact rates would decrease when susceptible individuals who accept the public health education contact with drug addicts, therefore, the factor $\xi \in \left( 0,1 \right)$ is brought into $\beta_{1}$ and $\beta_{2}$. Before accepting public health education, some susceptible individuals undergo the family education, so the proportions *q* and $1 - q$ denote the initial new recruit rate entering susceptible humans. By means of the next generation matrix, we got the basic reproduction number $R_{0}$ of system [(2)](#fd2){ref-type="disp-formula"}. The global stability of system [(2)](#fd2){ref-type="disp-formula"} has been proved by using the Lyapunov function. When $R_{0} \leq 1$, the drug-free equilibrium $E_{0}$ is globally asymptotically stable; when $R_{0} > 1$, the drug-addiction equilibrium $E^{\text{*}}$ is globally stable which indicates the drug problem will persist.

We also focus on the effect of family education and public health education on the dynamics of drug model. The sensitivity analysis implies both of them influence the spread of drug transmission. From [Fig. 3](#fig3){ref-type="fig"}, it is clear to see that increasing *q* and *μ* simultaneously could decrease the basic reproduction number $R_{0}$ more rapidly compared to just simply increasing *q* or *μ*, which could help government to take effect measures for controlling the drug spread.

7. Conclusion {#sec7}
=============

From a six dimensional drug transmission model, we study the effect of family education and public health education. The analysis show that both the family and public health education can influence the spread of drug transmission. However, the combination of family and public health education is more effective to reduce the prevalence of drugs than one of them simply.
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